Summary: Retatrutide diarrhoea is most common during dose escalation and typically begins to settle within one to two weeks of reaching a stable dose, though individual experience varies
The active pharmaceutical ingredients (semaglutide and tirzepatide) are based on FDA-approved compounds, but compounded formulations operate under the 503A regulatory pathway that allows pharmacies to customize medications for individual patients
The Verdict: Emerging area of interest, but more research is needed before taurine can be recommended specifically for GLP-1 support
Helps Promote a Feeling of Fullness: This formulation, featuring RevionLabs GLP-1 Support Drink Mix, includes psyllium husk extract, fenugreek, and plant-based fibers that promote fullness after consumption
Our firm expects media reports of gastrointestinal issues to grow, along with cases of blood clotting and vision loss in semaglutide users